3,511 results found

Patrick Ford, President and Chief Operating Officer of the OCS, noted that the agreements allow the province to "safely and securely provide a broad variety of cannabis products to adult consumers when online sales begin" on October 17, 2018.

On June 21, 2019, Bill C-97 received Royal Assent. Bill C-97 includes amendments to the Food and Drugs Act, including a new framework for "Advanced Therapeutic Products"

The Canadian Agency for Drugs and Technologies in Health (CADTH) released Issue 8 of its Pharmaceutical Reviews Update announcing updates

As of May 1, 2024 CADTH is no more, as it adopts its new operating name: Canada's Drug Agency (the "CDA"). The CDA expands on CADTH's existing mandate and functions to include:

Last week, in a both exciting and sobering press release, Canada announced a plan to fully "legalize, strictly regulate and restrict access" to cannabis in the Great White North. The release starts bluntly: "The current approach to cannabis does not work."

Health Canada's Food Directorate recently finalized a health claim on the ability of protein-rich soy foods to lower cholesterol.

CIHI: On December 17, the Canadian Institute for Health Information (CIHI) published statistics on drug spending, finding that in 2018, around 40% of drug spending was...

In October, 2013 the Government of Canada signed an Agreement in Principle on the Canada-European Union Comprehensive Economic and Trade Agreement (CETA) and released a technical summary of the negotiated outcomes. Many details of the agreement are still to be negotiated, with ratification of the final agreement targeted for 2015.

Commercialization of Cannabis

In particular, these food service establishments will be required to display the number of calories in each size and variety of food and drink item offered, as well as "any other information" required by the regulations.

Bill C-45 will now return to the House of Commons where the House will decide whether to accept or reject the Senate's amendments.

Welcome to the Fall/Winter 2015 edition of our Food & Beverage newsletter.

The Therapeutic Products Directorate, the Biologic and Radiopharmaceutical Drugs Directorate and the Natural and Non-Prescription Health Products Directorate have released their Drug Submission Performance Annual Reports ...

Health Canada has issued updated guidance reflecting the September 21, 2017 amendments: Guidance Document: Patented Medicines (Notice of Compliance) Regulations (see our summary of the amendments here).

On June 27, 2019, Health Canada published Drug and medical device highlights 2018: Helping you maintain and improve your health, an annual highlights report for 2018.

A look at the regulation, promotion and opportunities within the Canadian cannabis market

On May 28, 2019, Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQB:KHRNF) closed its previously announced bought deal short form prospectus offering of common shares, including the exercise in full of the over-allotment option